Kinase Domain Activation of FGFR2 Yields High-Grade Lung Adenocarcinoma Sensitive to a Pan-FGFR Inhibitor in a Mouse Model of NSCLC
Cancer Research - United States
doi 10.1158/0008-5472.can-13-3218
Full Text
Open PDFAbstract
Available in full text
Date
July 17, 2014
Authors
Publisher
American Association for Cancer Research (AACR)